
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
We speak with Rousselot’s principal scientist, Elhadji Dioum, about the company’s Nextida.GC collagen peptide product, which is designed to interact with GLP-1 and other weight loss medications. We discuss helping consumers maintain metabolic flexibility with blood glucose control.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement













